Secondary outcomes were changes in plasma C-reactive protein (CRP), the diversity of the faecal microbiota, quality of life (QoL) assessments and the incidence of upper respiratory tract infection (URTI). The gene discussed is CRP; the disease is Recurrent upper respiratory tract infections.